Str/581 Wk 5 Individual: Strategic Plan: Implementation Plan, Strategic Controls, And Contingency Plan Analysis

Wk 5 Individual: Strategic Plan: Implementation Plan, Strategic Controls, and Contingency Plan AnalysisNameCourseTutor’s NameDateStrategic Plan: Implementation Plan, Strategic Controls, and ContingencyThe most important strength that Acorda Therapeutics Inc. has is ability to develop and commercialize innovative therapies. The company has established specialization in the area of multiple sclerosis, spinal injury, Parkinson’s disease and nerve disorders, by exploiting this strength the company has developed a sizable market segment.The internal analysis of Acorda Therapeutics Inc. revealed the company has no control over the manufacture of products and is therefore exposes to the risk loss of revenue due to variance of demand as a major weakness. External environment scan has shown that innovation is the industry’s valuable strength. Firms in the industry will remain successful as long as can keep innovating and marketing new medical interventions. Multi-segment players with a global reach dominate the competitive landscape of the industry.ObjectivesThe objective of strategy implementation is growth through differentiated biotechnology medical products, a transformational pipeline of medical innovations and global product reach.This will be attained by positioning the company on top of the rapid